Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,051 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.
Focà E, Magro P, Guaraldi G, Riva A, Cattelan AM, De Socio GV, Costa C, Piconi S, Celesia BM, Nozza S, Orofino G, Castagna A, Di Perri G, Castelli F, Calcagno A; GEPPO (GEriatric Patients living with HIV/AIDS: a Prospective Multidimensional cOhort) Study Group. Focà E, et al. Among authors: riva a. PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019. PLoS One. 2019. PMID: 31622347 Free PMC article.
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.
Ferraris L, Viganò O, Peri A, Tarkowski M, Milani G, Bonora S, Adorni F, Gervasoni C, Clementi E, Di Perri G, Galli M, Riva A. Ferraris L, et al. Among authors: riva a. J Antimicrob Chemother. 2012 Sep;67(9):2236-42. doi: 10.1093/jac/dks175. Epub 2012 Jun 2. J Antimicrob Chemother. 2012. PMID: 22661571 Clinical Trial.
B-cell subset alterations and correlated factors in HIV-1 infection.
Pensieroso S, Galli L, Nozza S, Ruffin N, Castagna A, Tambussi G, Hejdeman B, Misciagna D, Riva A, Malnati M, Chiodi F, Scarlatti G. Pensieroso S, et al. Among authors: riva a. AIDS. 2013 May 15;27(8):1209-17. doi: 10.1097/QAD.0b013e32835edc47. AIDS. 2013. PMID: 23343911
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?
Gervasoni C, Meraviglia P, Minisci D, Ferraris L, Riva A, Landonio S, Cozzi V, Charbe N, Molinari L, Rizzardini G, Clementi E, Galli M, Cattaneo D. Gervasoni C, et al. Among authors: riva a. PLoS One. 2015 Apr 15;10(4):e0123670. doi: 10.1371/journal.pone.0123670. eCollection 2015. PLoS One. 2015. PMID: 25875091 Free PMC article.
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.
Malnati MS, Ugolotti E, Monti MC, Battista D, Vanni I, Bordo D, Sironi F, Larghero P, Marco ED, Biswas P, Poli G, Vicenzi E, Riva A, Tarkowski M, Tambussi G, Nozza S, Tripodi G, Marras F, De Maria A, Pistorio A, Biassoni R. Malnati MS, et al. Among authors: riva a. Sci Rep. 2017 Feb 13;7:42470. doi: 10.1038/srep42470. Sci Rep. 2017. PMID: 28211903 Free PMC article.
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
Giacomelli A, Riva A, Falvella FS, Oreni ML, Cattaneo D, Cheli S, Renisi G, Di Cristo V, Lupo A, Clementi E, Rusconi S, Galli M, Ridolfo AL. Giacomelli A, et al. Among authors: riva a. BMC Infect Dis. 2018 Nov 12;18(1):556. doi: 10.1186/s12879-018-3462-5. BMC Infect Dis. 2018. PMID: 30419834 Free PMC article.
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy.
Castagna A, Rusconi S, Gulminetti R, Bonora S, Mazzola G, Quiros-Roldan ME, De Socio GV, Ladisa N, Carosella S, Cattelan A, Di Giambenedetto S, Mena M, Poli A, Galli L, Riva A; DAU Study Group. Castagna A, et al. Among authors: riva a. AIDS. 2019 Jun 1;33(7):1256-1260. doi: 10.1097/QAD.0000000000002188. AIDS. 2019. PMID: 30870194 Free article.
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.
Guerrini G, Franzetti F, Giacomelli R, Meroni L, Riva A, Scirè CA, Scrivo R, Tavio M, Agostinone A, Airò P, Atzeni F, Bartalesi F, Bazzichi L, Berardicurti O, Cassola G, Castagna A, Castelli F, Cattelan A, Citriniti G, Cristini F, De Rosa F, Fracassi E, Galloway J, La Paglia GMC, Moioli MC, Ripamonti D, Saracino A, Tani C, Tascini C, Tieghi T, Tinelli M, Zabotti A, Sarzi-Puttini P, Galli M. Guerrini G, et al. Among authors: riva a. Clin Exp Rheumatol. 2020 Mar-Apr;38(2):245-256. doi: 10.55563/clinexprheumatol/hj69ne. Epub 2019 Aug 27. Clin Exp Rheumatol. 2020. PMID: 31498077 Free article.
1,051 results